0001415889-19-001208.txt : 20191022
0001415889-19-001208.hdr.sgml : 20191022
20191022170040
ACCESSION NUMBER: 0001415889-19-001208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191021
FILED AS OF DATE: 20191022
DATE AS OF CHANGE: 20191022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIN JERRY B
CENTRAL INDEX KEY: 0000901014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 191162174
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-10222019_051020.xml
X0306
4
2019-10-21
0001411685
VistaGen Therapeutics, Inc.
VTGN
0000901014
GIN JERRY B
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Stock Option (Right to Buy)
1.41
2019-10-21
4
A
0
75000
0
A
2029-10-21
Common Stock
75000
75000
D
25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter.
/s/ Jerrold D. Dotson, Attorney-in-Fact
2019-10-22